All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
BARINTHUS BIOTHERAPEUTICS PLC. Last Reported: 3/31/2024 Stock Symbol: BRNS

Business Address

UNIT 6-10, ZEUS BUILDING
RUTHERFORD AVENUE, HARWELL
DIDCOT , GB OX11 0DF

Mailing Address

UNIT 6-10, ZEUS BUILDING
RUTHERFORD AVENUE, HARWELL
DIDCOT , GB OX11 0DF
Phone Number: 44 (0) 1865 818808 / State Incorporated: / Fiscal Year End 12 /31

Balance Sheet

Date 9/30/2023 6/30/2023 12/31/2022 9/30/2022 6/30/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020
Cash and Cash Equivalents $160,309,000.00 $173,030,000.00 $194,400,000.00 $200,104,000.00 $192,327,000.00 $214,054,000.00 $233,871,000.00 $243,619,000.00 $155,935,000.00 $43,266,000.00 -- -- --
Accounts Receivable Net Current -- -- $323,000.00 $26,000.00 -- $20,000.00 $42,000.00 $37,000.00 $312,000.00 $518,000.00 -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $6,584,000.00 $8,261,000.00 $8,268,000.00 $8,248,000.00 $11,699,000.00 $6,462,000.00 $6,684,000.00 $8,514,000.00 $3,427,000.00 $1,409,000.00 -- -- --
Total Current Assets $171,065,000.00 $184,777,000.00 $213,041,000.00 $218,621,000.00 $226,291,000.00 $226,765,000.00 $245,979,000.00 $256,728,000.00 $163,365,000.00 $47,901,000.00 -- -- --
Property Plant and Equipement $12,269,000.00 $13,741,000.00 $7,957,000.00 $6,766,000.00 $7,044,000.00 $1,829,000.00 $1,033,000.00 $1,038,000.00 $1,003,000.00 $629,000.00 -- -- --
Intangible Assets Net $25,898,000.00 $26,688,000.00 $28,269,000.00 $29,059,000.00 $29,850,000.00 $31,430,000.00 -- -- -- -- -- -- --
Goodwill $12,209,000.00 $12,209,000.00 $12,209,000.00 $12,630,000.00 $12,630,000.00 $12,630,000.00 -- -- -- -- -- -- --
Other Assets -- -- -- -- -- -- -- -- -- -- -- -- --
Total Assets $229,970,000.00 $246,128,000.00 $270,205,000.00 $275,481,000.00 $285,056,000.00 $280,715,000.00 $256,571,000.00 $259,838,000.00 $166,491,000.00 $50,666,000.00 -- -- --
Accounts Payable $5,145,000.00 $2,429,000.00 $3,748,000.00 $2,411,000.00 $4,475,000.00 $2,419,000.00 $1,337,000.00 $4,683,000.00 $4,833,000.00 $4,667,000.00 -- -- --
Accrued Liabilities -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Liabilities $34,367,000.00 $28,666,000.00 $27,004,000.00 $31,329,000.00 $30,289,000.00 $28,153,000.00 $14,100,000.00 $9,927,000.00 $10,085,000.00 $53,813,000.00 -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Deficit $-159,300,000.00 $-145,200,000.00 $-103,243,000.00 $-82,054,000.00 $-90,296,000.00 $-108,585,000.00 $-93,472,000.00 $-88,915,000.00 $-72,988,000.00 $-57,720,000.00 -- -- --
Total Stockholders' Equity $195,398,000.00 $217,209,000.00 $242,896,000.00 $243,837,000.00 $254,401,000.00 -- -- -- -- -- -- -- --
Controlling Interest in Subsidiaries $205,000.00 $253,000.00 $305,000.00 $315,000.00 $366,000.00 $437,000.00 $493,000.00 $518,000.00 $277,000.00 $391,000.00 -- -- --
Total Liabilities and Equity $229,970,000.00 $246,128,000.00 $270,205,000.00 $275,481,000.00 $285,056,000.00 $280,715,000.00 $256,571,000.00 $259,838,000.00 $166,491,000.00 $50,666,000.00 -- -- --

Statement of Operations

Date 9/30/2023 6/30/2023 12/31/2022 9/30/2022 6/30/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $15,144,000.00 $13,543,000.00 $42,350,000.00 $30,165,000.00 $9,720,000.00 $20,371,000.00 $4,371,000.00 $9,119,000.00 $4,610,000.00 -- $3,702,000.00 $8,119,000.00 $4,242,000.00
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $16,105,000.00 $48,623,000.00 $48,744,000.00 $16,251,000.00 $3,275,000.00 $45,489,000.00 $28,822,000.00 $23,267,000.00 $6,387,000.00 -- $14,880,000.00 $10,201,000.00 $5,354,000.00
Loss from Operations $-63,926,000.00 $-47,821,000.00 $-4,041,000.00 $21,995,000.00 $13,788,000.00 $-45,221,000.00 $-28,553,000.00 $-23,017,000.00 $-6,172,000.00 -- $-1,428,000.00 $-8,985,000.00 $-4,649,000.00
Loss Before Income Taxes $-14,713,000.00 $-43,699,000.00 $850,000.00 -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-1.46 $-0.62 $0.14 $0.22 $0.49 $-1.96 $-1.58 -- -- -- $-0.92 -- --
Weighted Average Shares Basic 38,533,833 38,407,672 37,248,126 37,247,123 37,196,843 25,894,375 22,697,462 -- -- -- 7,937,384 -- --
Earnings Per Share Diluted $-1.46 $-0.62 $0.14 $0.22 $0.48 $-1.96 $-1.58 -- -- -- $0.01 -- --
Weighted Average Shares Diluted 38,533,833 38,407,672 38,169,307 38,226,092 38,260,579 25,894,375 34,843,154 -- -- -- 15,867,533 -- --
Common Stock Shares Authorized 38,546,594 38,524,059 37,683,531 37,291,492 37,216,162 37,188,730 34,328,231 34,328,231 8,224,344 7,960,458 -- -- --
Common Stock Shares Outstanding 38,546,594 38,524,059 37,683,531 37,291,492 37,216,162 37,188,730 34,328,231 34,328,231 8,224,344 7,960,458 -- -- --
Common Stock Value $1,000.00 $1,000.00 $1,000.00 $1,000.00 $1,000.00 $1,000.00 $1,000.00 $1,000.00 -- -- -- -- --
Common Stock Par Or Stated Value Per Share -- -- -- -- -- -- -- -- -- -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share -- -- -- -- -- -- -- -- -- -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com